Lithobid Tablet, Film Coated, Extended Release
Product Images NDC 62559-280

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithobid (NDC 62559-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ani (Ani)

FDA Label Image

Label (Image 01)

Each tablet of Lithobid contains 300 mg of Lithium Carbonate USP. The product meets USP Drug Release Test 1. For dosage and administration, refer to the accompanying prescribing information. The medication should be kept out of reach of children and stored in a tight, child-resistant container. The manufacturer is ANI Pharmaceuticals, Inc. and the tablets are for extended release. Store between 59° to 86°F (15° to 30°C). The provided text includes some unreadable characters and symbols.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.